national

President Trump Announces All 50 States Joining Medicaid Drug Pricing Program

Published

Just the facts

The program implements a Most Favored Nation pricing model designed to reduce prescription drug costs within Medicaid to match lower prices paid in select foreign nations. Flanked by Health and Human Services Secretary Robert F. Kennedy Jr. and Centers for Medicare & Medicaid Services Administrator Mehmet Oz, President Trump stated that the initiative will save billions of dollars for state healthcare budgets. While administration estimates project $529 billion in potential savings over ten years from pharmaceutical pricing agreements, public health analysts noted that specific terms of the commercial deals have not been publicly disclosed. Representatives from the Pharmaceutical Reform Alliance characterized the program as positive progress while noting that lower drug prices remain unavailable to Americans outside government healthcare programs.

Why this is news

On September 18, 2026, President Donald Trump announced in the Oval Office that all 50 U.S. states have joined the Medicaid GENEROUS drug pricing model.

Sources

This summary is compiled strictly from the original reporting below.

← All stories · Live timeline